Your browser doesn't support javascript.
loading
Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.
Foxwell, B; Andreakos, E; Brennan, F; Feldmann, M; Smith, C; Conron, M.
Affiliation
  • Foxwell B; The Kennedy Institute of Rheumatology Division, Imperial College London, The Charing Cross Campus, ARC Building, 1 Aspenlea Road, London W6 8LH, UK. b.foxwell@imperial.ac.uk
Ann Rheum Dis ; 62 Suppl 2: ii90-3, 2003 Nov.
Article in En | MEDLINE | ID: mdl-14532159
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Tumor Necrosis Factor-alpha / Antirheumatic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2003 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Tumor Necrosis Factor-alpha / Antirheumatic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2003 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom